Immunosuppressive Drug Use in Limited Systemic Sclerosis: An International Survey
Objective Current guidelines recommend immunosuppressive treatment for diffuse cutaneous systemic sclerosis but are less clear on their use in limited cutaneous systemic sclerosis (lcSSc) in the absence of internal organ complications. We conducted an international survey to understand current immunosuppressive drug prescribing patterns in lcSSc ...
Sabrina Hoa +3 more
wiley +1 more source
Ceftazidime-Avibactam: A Retrospective Analysis of Multicenter Real-World Data and Factors Affecting Mortality. [PDF]
Aktuğ Demir N +22 more
europepmc +1 more source
Distinct Systemic Sclerosis Phenotypes Related to Ethnicity: An Opportunity to Personalize Care?
Objective The objective is to describe and compare demographic, clinical, and serological characteristics of patients with systemic sclerosis (SSc) according to ethnic background. Methods Participants enrolled in the Canadian Scleroderma Research Group cohort who self‐identified to a single ethnicity group were included.
Danick Goulet +11 more
wiley +1 more source
Autophagy markers in umbilical cord blood-derived PBMCs and their association with preterm morbidities: a prospective multicenter cohort study. [PDF]
Armağan C +15 more
europepmc +1 more source
Surgical glove perforation in caesarean section and its association with surgical site infections: a prospective cohort study. [PDF]
Akbulut VÖ +9 more
europepmc +1 more source
Middle Pleistocene tectonic events around the SE Aegean Sea: Insights from magnetostratigraphy, (U-Th)/He zircon dating, and fault kinematics in the Datça Graben (SW Türkiye). [PDF]
İnce MD +7 more
europepmc +1 more source
Targeting severe acidity for tumor-activatable Interleukin-2 therapy. [PDF]
Feng Q +13 more
europepmc +1 more source
Stimuli-responsive STING nanovaccine for systemic therapy of HPV-induced cancers. [PDF]
Chen S +8 more
europepmc +1 more source
Split-screen distraction: the role of extraneous visual demands in learning from video. [PDF]
Schuetze BA.
europepmc +1 more source

